Printer Friendly
The Free Library
14,381,205 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Proneuron Biotechnologies.


Proneuron Biotechnologies has named Dr. Marca Sipski to its Procord Study Steering Committee, which is charged with overseeing the Phase II study of ProCord, an experimental procedure for complete spinal cord injury Spinal Cord Injury Definition

Spinal cord injury is damage to the spinal cord that causes loss of sensation and motor control.
Description

Approximately 10,000 new spinal cord injuries (SCIs) occur each year in the United States.
 now in progress in the U.S and Israel. Sipski is a professor of rehabilitation medicine rehabilitation medicine Physiatry, physiotherapy A field of therapeutics that bridges the gap between conventional and nonconventional medicine; rehabilitation physicians may adminsiter or prescribe mechanical–eg, massage, manipulation, exercise, movement,  at the University of Miami This article is about the university in Coral Gables, Florida. For the university in Oxford, Ohio, see Miami University.

The University of Miami (also known as Miami of Florida,[2] UM,[3] or just The U
 School of Medicine.
COPYRIGHT 2004 CBJ, L.P.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Marca Sipski; Proneuron Biotechnologies Incorporation
Publication:Los Angeles Business Journal
Article Type:Brief Article
Geographic Code:7ISRA
Date:Sep 13, 2004
Words:56
Previous Article:Automat Pictures Inc.(Entertainment)(Laura Nix)(Brief Article)
Next Article:HeartSTAT Technology Inc.(Health Care)(James Hudson)(Brief Article)
Topics:



Related Articles
PRONEURON STARTS 2ND PHASE 1 SPINAL CORD INJURY CLINICAL TRIAL.
PRONEURON/CRAIG HOSPITAL TO DEVELOP MACROPHAGE THERAPY FOR SCI.
Proneuron Announces FDA Approval of Further Recruitment of Patients with Spinal Cord Injury for Its Macrophage Therapy Following the Completion of...
Progenitor Cell Therapy to Provide the Platform for Cell Processing for Proneuron's Clinical Trials with ProCord in New York and New Jersey.
Proneuron Cell Processing Platform in Denver is Ready for the Clinical Trials with ProCord.
Proneuron Biotechnologies Inc. Announces Phase II Trial of Copolymer-1 for the Treatment of Patients with Huntington's Disease; Clinical Trial to...
Proneuron Biotechnologies Announces a Phase II IND Study of Macrophage Therapy -- ProCord -- for the Treatment of Complete Spinal Cord Injury.
Proneuron Biotechnologies Pre-Clinical Study Shows that Primed Macrophages Enhance Recovery of Function and Preserve the Integrity of a Severely...
Proneuron Receives Award for Outstanding Contribution to the New Jersey-Israel Life Science Year in the Area of Spinal Cord and CNS Treatments.
Proneuron Biotechnologies Teams with Craig Hospital in Denver to Expand IND Phase II Trial of ProCord for the Treatment of Spinal Cord Injuries to...

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles